Pegasus Therapeutics is combining the latest technology in non-surgical aneurysm treatment and coronary artery stenting to design a bioresorbable flow diverter: a medical device that gives the body a chance to heal and then dissolves away completely after the therapeutic timeframe. Our vision is for children with coronary artery aneurysms to live longer, healthier, more productive lives. ​

Our Story:

​​

In 2012, our CEO's daughter Allison was diagnosed with Kawasaki Disease, the leading cause of acquired heart disease in children in the United States and many other nations around the world. Once her condition stabilized, Allison was left with two giant aneurysms in her coronary arteries -- a condition that most often leads to open heart surgery at a young age. Unsatisfied with the current treatment options, Allison's father set out to design a non-surgical device that meets the unique demands of pediatric use -- something that could help Allison's arteries heal without getting in the way of natural vessel growth.